KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:开放图源暂不可得 入排置信度 0.90

Red light photodynamic therapy with 10% aminolevulinic acid gel showed efficacy for treatment of superficial basal cell carcinoma in a randomized, vehicle controlled, double-blind, multicenter phase III study.

Todd Schlesinger, M Shane Chapman, John H Tu, Joel L Cohen, John Strasswimmer, Nathalie C Zeitouni, Abel Torres, S Sasha Jazayeri, Mitchel P Goldman, Sherrif F Ibrahim, Edward L Lain, Megan P Couvillion, Suzanne Bruce, Vivian T Laquer, C William Hanke, David M Ozog, Jane Schneider, Orit Markowitz, Brian Berman, Mark S Nestor, Michael H Gold, Girish S Munavalli, Douglass W Forsha, Daniel M Siegel, David Mrohs, Beate Schmitz, Ruth Schäning, Nicole Pospiech, Jon Lyons, Montserrat Foguet, Matthias Lübbert, Hermann Lübbert, David M Pariser

J Am Acad Dermatol 93(6) 1489-1498

PMID40846240
PMCID-
DOI10.1016/j.jaad.2025.08.031
发表日期2025-08-22
入排依据:The study meets most criteria (oncology, human, randomized, Phase III, original result), but lacks a time-to-event primary or key secondary efficacy endpoint. The efficacy endpoints are histological and clinical clearance rates at a fixed timepoint, not time-to-event outcomes such as OS, PFS, DFS, or those analyzed via Kaplan-Meier/HR.
PubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。
摘要

摘要

BACKGROUND: Surgical procedures remain the gold standard for treating basal cell carcinoma (BCC), although commonly associated with cosmetic defects. The demand for noninvasive alternatives remains high. OBJECTIVE: To determine efficacy and safety of red light photodynamic therapy (PDT) with 10% 5-aminolevulinic acid (ALA) gel vs vehicle for treatment of superficial BCC. METHODS: This randomized, double-blind, vehicle-controlled, pivotal phase III study was conducted at 21 centers in the US. Eligible participants had ≥1 naïve superficial BCC and received 1-2 PDT cycles (2 PDTs each cycle) followed by clinical and histological assessment 12 weeks after start of the last PDT cycle. RESULTS: Of 187 randomized participants, 145 received PDT with 10% ALA gel and 42 with vehicle. Histological clearance was 75.9% with 10% ALA gel vs 19.0% with vehicle (P < .0001). Clinical clearance was 83.4% with 10% ALA gel vs 21.4% with vehicle (P < .0001). A total of 88.1% of participants treated with 10% ALA gel rated the esthetic outcome as very good or good. No previously unknown adverse events occurred. LIMITATIONS: Few participants with lesions on face/scalp; to date, a 60-month follow-up is still ongoing. CONCLUSION: 10% ALA gel showed significantly higher clearance rates than vehicle with unproblematic safety and positive esthetic outcome.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。